Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
Tenon Medical (NASDAQ:TNON), a company focused on treating Sacroiliac Joint (SIJ) disorders, has announced that CFO Kevin Williamson will conduct one-on-one investor meetings during the 43rd Annual J.P. Morgan Healthcare Conference week in San Francisco, starting January 13th, 2025.
The conference is recognized as the healthcare industry's premier global investment forum, featuring over 500 healthcare companies and bringing together executives, investors, and innovators from across the healthcare sector. The event showcases innovations in biotechnology, pharmaceuticals, and healthcare technologies.
Interested parties can schedule meetings with Tenon's management by contacting their investor relations team at tenon@mzgroup.us.
Tenon Medical (NASDAQ:TNON), un'azienda focalizzata sul trattamento dei disturbi dell'Articolazione Sacroiliaca (SIJ), ha annunciato che il CFO Kevin Williamson condurrà incontri individuali con gli investitori durante la settimana della 43ª Conferenza Sanitaria Annuale J.P. Morgan a San Francisco, a partire dal 13 gennaio 2025.
La conferenza è riconosciuta come il principale forum di investimento globale dell'industria sanitaria, con oltre 500 aziende sanitarie e riunendo dirigenti, investitori e innovatori provenienti da tutto il settore sanitario. L'evento mette in mostra innovazioni in biotecnologia, prodotti farmaceutici e tecnologie sanitarie.
Le parti interessate possono programmare incontri con la direzione di Tenon contattando il loro team relazioni con gli investitori all'indirizzo tenon@mzgroup.us.
Tenon Medical (NASDAQ:TNON), una compañía centrada en el tratamiento de trastornos de la Articulación Sacroilíaca (SIJ), ha anunciado que el CFO Kevin Williamson llevará a cabo reuniones individuales con inversores durante la semana de la 43ª Conferencia Anual de Salud J.P. Morgan en San Francisco, comenzando el 13 de enero de 2025.
La conferencia es reconocida como el principal foro global de inversión de la industria de la salud, con más de 500 empresas de salud y reuniendo a ejecutivos, inversores e innovadores de todo el sector sanitario. El evento exhibe innovaciones en biotecnología, farmacéuticos y tecnologías de salud.
Las partes interesadas pueden programar reuniones con la dirección de Tenon contactando a su equipo de relaciones con inversores en tenon@mzgroup.us.
Tenon Medical (NASDAQ:TNON), 천골 관절(SIJ) 장애 치료에 중점을 둔 회사는 CFO Kevin Williamson이 2025년 1월 13일부터 시작되는 샌프란시스코에서 열리는 제43회 JP모건 헬스케어 컨퍼런스 주간 동안 개별 투자자 회의를 진행할 것이라고 발표했습니다.
이 컨퍼런스는 500개 이상의 헬스케어 기업이 참여하며 헬스케어 부문의 경영자, 투자자 및 혁신가들이 모이는 헬스케어 산업의 주요 글로벌 투자 포럼으로 인정받고 있습니다. 이 행사에서는 생명공학, 제약 및 헬스케어 기술의 혁신이 전시됩니다.
관심 있는 당사자는 tenon@mzgroup.us로 투자자 관계 팀에 연락하여 Tenon의 경영진과 회의를 예약할 수 있습니다.
Tenon Medical (NASDAQ:TNON), une entreprise axée sur le traitement des troubles de l'articulation sacro-iliaque (SIJ), a annoncé que le CFO Kevin Williamson participera à des réunions individuelles avec des investisseurs lors de la semaine de la 43e Conférence Annuelle J.P. Morgan sur la Santé à San Francisco, à partir du 13 janvier 2025.
La conférence est reconnue comme le principal forum d'investissement mondial de l'industrie de la santé, rassemblant plus de 500 entreprises de santé et réunissant des dirigeants, des investisseurs et des innovateurs de tout le secteur de la santé. L'événement met en avant des innovations en biotechnologie, en produits pharmaceutiques et en technologies de la santé.
Les parties intéressées peuvent planifier des réunions avec la direction de Tenon en contactant leur équipe des relations investisseurs à l'adresse tenon@mzgroup.us.
Tenon Medical (NASDAQ:TNON), ein Unternehmen, das sich auf die Behandlung von Störungen des Sakroiliakalgelenks (SIJ) spezialisiert hat, hat bekannt gegeben, dass CFO Kevin Williamson während der Woche der 43. jährlichen J.P. Morgan Healthcare-Konferenz in San Francisco, die am 13. Januar 2025 beginnt, Einzelgespräche mit Investoren führen wird.
Die Konferenz gilt als das führende globale Investitionsforum der Gesundheitsbranche, mit über 500 Gesundheitsunternehmen und bringt Führungskräfte, Investoren und Innovatoren aus dem Gesundheitssektor zusammen. Die Veranstaltung präsentiert Innovationen in Biotechnologie, Pharmazeutik und Gesundheitstechnologien.
Interessierte Parteien können Meetings mit dem Management von Tenon vereinbaren, indem sie ihr Investor-Relations-Team unter tenon@mzgroup.us kontaktieren.
- None.
- None.
LOS GATOS, CA / ACCESSWIRE / January 9, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced that Chief Financial Officer Kevin Williamson will host one-on-one investor meetings in San Francisco, CA during the week of January 13th in accordance with the 43rd Annual J.P. Morgan Healthcare Conference.
The J.P. Morgan Healthcare Conference is the industry's leading global investment forum, bringing together top executives, investors, and innovators across the healthcare ecosystem. With over 500 healthcare companies presenting, the event showcases groundbreaking advancements in biotechnology, pharmaceuticals, and healthcare technologies.
To arrange a meeting with management during the week of the conference, please contact Tenon Medical investor relations at tenon@mzgroup.us.
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022 Tenon is focused on two commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, and 2) Revision procedures of failed SI Joint implants. For more information, please visit www.tenonmed.com.
The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, and Catamaran Transfixation Fusion Device® are registered trademarks of Tenon Medical, Inc. MAINSAILTM is also a trademark of Tenon Medical, Inc.
IR Contact:
Shannon Devine / Rory Rumore
203-741-8811
MZ North America
tenon@mzgroup.us
SOURCE: Tenon Medical, Inc.
View the original press release on accesswire.com
FAQ
When and where is Tenon Medical (TNON) hosting investor meetings in January 2025?
How many companies are presenting at the 2025 J.P. Morgan Healthcare Conference where TNON is participating?
What is the focus area of Tenon Medical (TNON) in the healthcare sector?
How can investors arrange meetings with Tenon Medical (TNON) management at the 2025 J.P. Morgan conference?
Which Tenon Medical executive will be hosting meetings at the 2025 J.P. Morgan Healthcare Conference?
